Bausch + Lomb Initiates Recall of enVista Cataract Surgery Lenses

Fri 11th Apr, 2025

Bausch + Lomb has announced a voluntary recall of specific intraocular lenses from its enVista product line due to concerns regarding the potential for acute postoperative inflammatory reactions. This action includes all lots of the enVista Aspire, enVista Aspire Toric, enVista Envy, enVista Envy Toric, as well as enVista monofocal and enVista monofocal Toric lenses distributed within the United States.

The recall stems from reports of toxic anterior segment syndrome (TASS), a sterile inflammatory reaction that typically manifests in the anterior chamber of the eye within 12 to 48 hours post-surgery. Fortunately, all patients who experienced TASS symptoms related to the enVista lenses responded well to treatment, and none required removal of the lenses. Bausch + Lomb is actively investigating the underlying causes of these reported complications.

In a statement addressing the situation, the company emphasized its commitment to patient safety as the foremost priority. The CEO of Bausch + Lomb expressed confidence in the enVista platform while acknowledging the necessity of the recall to maintain the trust of both healthcare professionals and patients. He noted that the incidents reported represent only a small fraction, estimated at 1 to 2% of all implanted lenses, and that the prognosis for affected patients is positive. The company is dedicated to identifying the root cause of the issues and aims to reintroduce the enVista platform to the market once resolved.

Patients who have undergone cataract surgery with these lenses are advised to contact their eye care providers promptly if they experience any discomfort or unusual symptoms. Eye care professionals are urged to maintain vigilant monitoring of patients for at least 48 hours following surgery and to inform them to report any new or worsening symptoms immediately.

This recall serves as a reminder of the importance of ongoing vigilance in patient care and the need for manufacturers to ensure the highest safety standards in medical devices.


More Quick Read Articles »